dihexa pnb-0408 c-met hgfr activator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion HGF/c-MET pathway in cancer: from
HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



